Glycogen Storage Disease Type II

Rare Disease·MeSH: Glycogen Storage Disease Type II

Prevalence

5.0 / 100K

5 drugs in development·3 companies·4 clinical trials

Drug Pipeline by Phase

Compare drugs

avalglucosidase alfa vs Cipaglucosidase Alfaavalglucosidase alfa vs Miglustatavalglucosidase alfa vs alglucosidase alfa

Frequently asked questions

How many drugs are in development for Glycogen Storage Disease Type II?

BioSniper tracks 5 drugs in development for Glycogen Storage Disease Type II across 3 companies.

How many clinical trials target Glycogen Storage Disease Type II?

There are 4 clinical trials targeting Glycogen Storage Disease Type II tracked by BioSniper.

What is the prevalence of Glycogen Storage Disease Type II?

The estimated prevalence of Glycogen Storage Disease Type II is approximately 5.0 per 100,000 population.

Deep-dive into Glycogen Storage Disease Type II

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Glycogen Storage Disease Type II — Drugs in Development & Clinical Trials | BioSniper